Uveitis

Taking treatment beyond adalimumab

An update on biologic alternatives for ocular inflammatory disease when the approved agent just won’t cut it.

How COVID-19 has altered uveitis management

The pandemic has potentially changed the risk-benefit balance between local therapy and systemic immunosuppression.

Noninfectious uveitis in pregnancy

Knowing the options available for safely treating pregnant patients will empower retina specialists to confidently care for them.

PPV in the management of uveitis

Pars plana vitrectomy can be an important tool in the diagnosis and treatment of uveitic disease in carefully selected patients.

Managing TRC in posterior uveitis

Guidance for detecting and managing toxoplasmosis retinochoroiditis.

When to consider systemic treatments

Scenarios for systemic immunosuppression, and where conventional immunosuppressants and biologics fit in.

Avoid these pitfalls when ordering labs

More testing doesn’t necessarily result in better patient care and can lead to unnecessary lab work.

How OCT is aiding uveitis management

Optical coherence tomography helps grade inflammation and evaluate the vitreous, retinal vasculature and choroid.

Current and new steroid therapy in noninfectious uveitis

Corticosteroid therapy is the cornerstone of treatment. Sustained delivery systems and concomitant use with other medications are expanding options.

Noninfectious Uveitis: Enriching Our Toolbox

Recent advances in localized therapies provide options to traditional systemic immunosuppression.

Video Vault

Minimally invasive management of lenticular deposits

Akshay Thomas, MD, MS, of Tennessee Retina demonstrates his surgical technique for removing posterior intraocular lens deposits.